Back to Search
Start Over
[Means for the inhibition of the nonimmune progression of nephritis].
- Source :
-
Klinicheskaia meditsina [Klin Med (Mosk)] 1995; Vol. 73 (3), pp. 80-3. - Publication Year :
- 1995
-
Abstract
- Inhibition of non-immune progression of renal insufficiency for control of glomerulonephritis was attempted via hemodynamic, metabolic and hypolipidemic means. Hemodynamic correction was conducted using inhibitors of angiotensin-converting enzyme capoten and renitek. The action on metabolic factors of progression was realized by lovastatin mevakor. Capoten and renitek exhibited in 57 patients with chronic nephritis not only a hypotensive effect, but also reduced intraglomerular hypertension and proteinuria. A long-term (7-12 months) hypolipidemic therapy (diet and lovastatin) in 20 patients with chronic glomerulonephritis with nephrotic syndrome resulted in lowering of serum cholesterol concentrations and proteinuria, raised serum albumin. 9 patients achieved remission of nephrotic syndrome. The highest effect occurred in non-inflammatory nephropathy: membranous nephropathy, focal-segmental glomerulosclerosis, nephrosclerosis.
- Subjects :
- Angiotensin-Converting Enzyme Inhibitors therapeutic use
Blood Pressure drug effects
Calcium Channel Blockers therapeutic use
Chronic Disease
Combined Modality Therapy
Disease Progression
Drug Therapy, Combination
Glomerulonephritis diet therapy
Glomerulonephritis drug therapy
Humans
Hypolipidemic Agents therapeutic use
Nephritis diet therapy
Proteinuria diet therapy
Proteinuria drug therapy
Nephritis drug therapy
Subjects
Details
- Language :
- Russian
- ISSN :
- 0023-2149
- Volume :
- 73
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Klinicheskaia meditsina
- Publication Type :
- Academic Journal
- Accession number :
- 8577123